GenPad Test Kits

Test Kit for SARS-CoV-2 and Influenza A/B RNA PCR Detection

Rapid Cartridge/Tests kit
ref ID LP-CF-100IC
Introduction

The Kit is intended to perform the SARS-CoV-2, Influenza A, Influenza B viral RNA extraction from nasopharyngeal or oropharyngeal swabs collected from individuals who are suspected of COVID-19 or Influenza infections and further SARS-CoV-2, Influenza A, Influenza B viral RNA detection in the specimen using SmartAmp PCR method. The Kit is intended for use with the GenPad Analyzer.


Product Description
  • Name
    Test Kit for SARS-CoV-2 and Influenza A/B RNA PCR Detection
  • Ref ID
    ID LP-CF-100IC
  • Technology
    NAAT (RT-SmartAMP)
  • Time to results
    20-40 minutes
  • Equipment
    Portable device GenePad
Key Benefits
High accuracy
Sensitivity >98%, specificity 100%
Ease of use
Suitable for maternities, clinics, hospitals, and mobile setups
Rapid Diagnosis
Possibility to provide treatment in time
Instruction for Use
The test involves a single-step pre-treatment process to lyse the viral capsid of coronavirus and influenza viruses in the specimens. Following pre-treatment, the test employs fully automated processes, including RNA extraction and isothermal nucleic acid amplification. The method is based on the detection of specific viral RNA fragments by obtaining a DNA copy (cDNA) from the RNA matrix using a reverse transcription reaction and detection of its accumulation (amplification) using SmartAmp Real-Time PCR method. Amplification is detected by the analyzer through fluorogenic oligonucleotides in the reaction mixture.

Documents
Interested in GenPad ?
At Mirai Genomics we always welcome great partners and distributors.
We look forward to hearing from you.
+351 963774706
info@miraigenomics.com
* required
KK Mirai Genomics
OFFICE: Ask Sanshin 2-6-29, Tsurumi-Chuo, Tsurumi-ku, Yokohama-shi, Kanagawa-ken, Japan
LifePad Europe
OFFICE: Rua Manuel Pinheiro Chagas 9, 4A, 2780-069 Oeiras, Portugal
Mirai Genomics UK Ltd
120 Lambton Road
SW20 0TJ, UK
Made on
Tilda